Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival (Q46332916)
scientific article published in January 2009
Language:
Current Data About Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival
(P31) (Q13442814)
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

(P50) (Q42716920)
(P1545) 5
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

(Q38328476)
(P1545) 9
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

(Q88011784)
(P1545) 7
(P1932) David Zagzag
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

(P304) 173-180
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

(P407) (Q1860)

(P433) 1
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

(P478) 110
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

(P577) Thursday, January 1, 2009
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

(P921) (Q181600)
(P887)

(Q413299)
(P887)

(Q574834)
(P887)

(P1104) 8
(P887)

(P1433) (Q15708886)
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

(P1476) "Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival" (language: en)
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

(P2093) Ashwatha Narayana
(P1545) 1
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

Patrick Kelly
(P1545) 2
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

John Golfinos
(P1545) 3
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

Erik Parker
(P1545) 4
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

Edmond Knopp
(P1545) 6
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

Ingeborg Fischer
(P1545) 8
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

Praveen Medabalmi
(P1545) 10
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

Patricia Eagan
(P1545) 11
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

Michael L Gruber
(P1545) 12
(P248)
(P698) 18834263
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18834263

other details
description scientific article published in January 2009

External Links
(P356) 10.3171/2008.4.17492
(P698) 18834263